3.0(top 20%)
impact factor
2.6K(top 10%)
papers
52.4K(top 5%)
citations
90(top 5%)
h-index
3.2(top 20%)
extended IF
3.2K
all documents
56.6K
doc citations
126(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer TissuesClinical Breast Cancer2004603
2Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast CancerClinical Breast Cancer2009597
3The Global Breast Cancer Burden: Variations in Epidemiology and SurvivalClinical Breast Cancer2005491
4Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial DesignClinical Breast Cancer2009416
5Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with TrastuzumabClinical Breast Cancer2005342
6Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer SurvivorsClinical Breast Cancer2013272
7Stress Management and Resilience Training (SMART) Program to Decrease Stress and Enhance Resilience Among Breast Cancer Survivors: A Pilot Randomized Clinical TrialClinical Breast Cancer2011252
8TAILORx: Trial Assigning Individualized Options for Treatment (Rx)Clinical Breast Cancer2006249
9Classification, Treatment Strategy, and Associated Drug Resistance in Breast CancerClinical Breast Cancer2016232
10Insulin-Lowering Effects of Metformin in Women with Early Breast CancerClinical Breast Cancer2008227
11Genetic Markers in Triple-Negative Breast CancerClinical Breast Cancer2018203
12Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up ResultsClinical Breast Cancer2009200
13Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET TrialClinical Breast Cancer2021194
14Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with TaxanesClinical Breast Cancer2007169
15Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic ReviewClinical Breast Cancer2018160
16Cancer-related Fatigue in Breast Cancer Survivors: A ReviewClinical Breast Cancer2021160
17The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysisClinical Breast Cancer2019159
18Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen TrialClinical Breast Cancer2002158
19The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast CancerClinical Breast Cancer2021158
20Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer PatientsClinical Breast Cancer2002155
21Incidence and Patterns of Distant Metastases for Patients With Early-Stage Breast Cancer After Breast Conservation TreatmentClinical Breast Cancer2013154
22Molecular Mechanisms of Breast Cancer Metastases to BoneClinical Breast Cancer2005152
23Results of a Diet/Exercise Feasibility Trial to Prevent Adverse Body Composition Change in Breast Cancer Patients on Adjuvant ChemotherapyClinical Breast Cancer2008152
24Breast Cancer Chemotherapy-Related Cognitive DysfunctionClinical Breast Cancer2002150
25Metastasis Suppressor Genes: Basic Biology and Potential Clinical UseClinical Breast Cancer2003144
26Circulating Tumor Cells in Metastatic Breast Cancer: Biologic Staging Beyond Tumor BurdenClinical Breast Cancer2007144
27Heterogeneity of Triple-Negative Breast Cancer: Histologic Subtyping to Inform the OutcomeClinical Breast Cancer2013144
28Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast CancerClinical Breast Cancer2008142
29The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled TrialClinical Breast Cancer2010140
30Peripheral Neuropathy with Microtubule-Targeting Agents: Occurrence and Management ApproachClinical Breast Cancer2011140
31Metastatic Breast Cancer: The Treatment ChallengeClinical Breast Cancer2008138
32Adjuvant Chemotherapy for Breast Cancer: Effects on Cerebral White Matter Seen in Diffusion Tensor ImagingClinical Breast Cancer2008138
33Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast CancerClinical Breast Cancer2011138
34Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of LiteratureClinical Breast Cancer2017138
35Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252Clinical Breast Cancer2005137
36Mammalian Target of Rapamycin: A New Molecular Target for Breast CancerClinical Breast Cancer2003136
37Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast CancerClinical Breast Cancer2014135
38Alarming Burden of Triple-Negative Breast Cancer in IndiaClinical Breast Cancer2018134
39Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data AnalysisClinical Breast Cancer2018134
40CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast CancerClinical Breast Cancer2010132
41Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital DatabaseClinical Breast Cancer2010131
42A Novel Approach Toward Development of a Rapid Blood Test for Breast CancerClinical Breast Cancer2003130
43Effects of Tai Chi Chuan on Insulin and Cytokine Levels in a Randomized Controlled Pilot Study on Breast Cancer SurvivorsClinical Breast Cancer2011128
44Radiomics Analysis on Ultrasound for Prediction of Biologic Behavior in Breast Invasive Ductal CarcinomaClinical Breast Cancer2018126
45Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case HistoriesClinical Breast Cancer2004124
46Treatment of Metastatic Breast Cancer with Trastuzumab and Vinorelbine During PregnancyClinical Breast Cancer2005124
47Aromatase Inhibitor–Associated Arthralgia and/or Bone Pain: Frequency and Characterization in Non–Clinical Trial PatientsClinical Breast Cancer2007124
48Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and PathogenesisClinical Breast Cancer2010124
49E2100: A Phase III Trial of Paclitaxel Versus Paclitaxel/Bevacizumab for Metastatic Breast CancerClinical Breast Cancer2003123
50Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysisClinical Breast Cancer2017122